CHEOF - Cochlear Limited
NYSE * Healthcare * Medical Devices
$144.54
+$0.00 (+0.00%)
About Cochlear Limited
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
CHEOF Key Statistics
Market Cap
$11.64B
P/E Ratio
47.98
P/B Ratio
6.93
EPS
$3.71
Dividend Yield
0.02%
Revenue Growth
-0.0%
Profit Margin
0.1%
Employees
5,500
How CHEOF Compares to Peers
P/E Rank
#5
of 6
Margin Rank
#2
of 6
Growth Rank
#6
of 6
Size Rank
#6
of 6
Cochlear Limited Company Information
- Headquarters
- 1 University Avenue, Sydney, NSW, Australia, 2109, undefined
- Website
- www.cochlear.com
- Sector
- Healthcare
- Industry
- Medical Devices